SI
DGX icon

Severin Investments’s Quest Diagnostics DGX Stock Holding History

Severin Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Buy
1,650
+80
+5% +$15.7K 0.26% 141
2026
Q1 		$308K Buy
1,570
+4
+0.3% +$777 0.26% 143
2025
Q4 		$272K Sell
1,566
-129
-8% -$23.5K 0.24% 155
2025
Q3 		$323K Buy
1,695
+15
+0.9% +$2.66K 0.29% 143
2025
Q2 		$302K Buy
1,680
+3
+0.2% +$521 0.28% 145
2025
Q1 		$284K Buy
1,677
+72
+4% +$11.8K 0.28% 157
2024
Q4 		$242K Buy
+1,605
New +$250K 0.24% 171

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Severin Investments's DGX Position: Q2 2026 in Review

Severin Investments increased its Quest Diagnostics (DGX) stake by 5.1% in Q2 2026, buying an estimated $15.7K and bringing the position to 1,650 shares worth $350K. The position accounts for 0.26% of the portfolio, ranked #141.

Severin Investments first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Severin Investments held 1,650 shares of Quest Diagnostics worth $350K as of Q2 2026.
  • Severin Investments bought 80 Quest Diagnostics shares in Q2 2026, an estimated $15.7K.
  • Quest Diagnostics made up 0.26% of Severin Investments's portfolio in Q2 2026, its #141 holding.
  • Severin Investments first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Severin Investments's 13F filing for Q2 2026, filed 14 Aug 2026.